The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 14, 2017

Filed:

Jan. 07, 2014
Applicant:

Biomedical Research Models, Inc., Worcester, MA (US);

Inventors:

Kejian Yang, Worcester, MA (US);

Dennis L. Guberski, Worcester, MA (US);

Assignee:

BIOMEDICAL RESEARCH MODELS, INC., Worcester, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); A61K 39/00 (2006.01); A61K 39/245 (2006.01); C07K 16/08 (2006.01); C07K 14/03 (2006.01); C07K 14/035 (2006.01); A61K 38/00 (2006.01); C07K 14/005 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 38/00 (2013.01); A61K 39/245 (2013.01); A61K 2039/543 (2013.01); A61K 2039/55555 (2013.01); C07K 14/005 (2013.01); C07K 14/03 (2013.01); C07K 14/035 (2013.01); C07K 16/085 (2013.01); C12N 2710/16634 (2013.01);
Abstract

The invention provides methods and kits for inducing a therapeutic immunity in animals (e.g. mammals) against viral antigens, including herpes-simplex virus type 2. In particular, the invention provides a method of treating animals with an established HSV-2 infection by administering a therapeutic vaccine comprising a priming dose of a nucleic acid encoding an HSV-2 antigen, an initial or first boosting dose comprising the protein form of the antigen encapsulated in liposomes, and one or more subsequent boosting doses comprising both the nucleic acid encoding the HSV-2 antigen and the liposomal-encapsulated protein antigen.


Find Patent Forward Citations

Loading…